Yan Wu,
Xi Wang,
Ying Ling* and
Haoyu Tang*
Key Laboratory of Polymeric Materials and Application Technology of Hunan Province, Key Laboratory of Advanced Functional Polymer Materials of Colleges and Universities of Hunan Province, College of Chemistry, Xiangtan University, Xiangtan, Hunan 411105, China. E-mail: htang@xtu.edu.cn; yingling0202@gmail.com
First published on 29th April 2015
Water-soluble polypeptides bearing various pyridinium groups (i.e., pyridinium, 2-methylpyridinium, 3-methylpyridinium, 4-methylpyridinium) and Cl− counter-anions have been prepared by nuleophilic substitutions between poly(γ-3-chloropropyl-L-glutamate) (PCPLG) or poly(γ-6-chlorohexyl-L-glutamate) (PCHLG) and pyridine or y-methyl pyridine (y = 2, 3, and 4). Polypeptides bearing pyridinium groups and BF4− counter-anions were prepared by ion-exchange reactions from the polypeptide–pyridinium conjugates with Cl− counter-anions. CD analysis revealed that water-soluble polypeptides adopted α-helical conformation in solutions with a fractional helicity in the range of 24.7–41.4%. Variable-temperature UV-vis spectroscopy revealed that polypeptides bearing 3-methylpyridinium and BF4− counter-anions (i.e., P11 and P15) showed upper critical solution temperature (UCST)-type transitions in aqueous solutions. The UCST-type phase transition temperatures increased as increasing the hydrophobicity of the spacer groups, the polymer concentrations, and the concentrations of NaBF4.
Synthetic polypeptides are mimics of natural peptides with excellent biocompatibility and unique secondary structures (e.g., α-helix and β-sheet).20–22 They have showed immense potential as biomedical materials, such as tissue-engineering scaffolds, drug-delivery carriers and antimicrobial agents.23–27 While water-soluble LCST-type polypeptides have been developed by incorporation of oligo-ethylene-glycol pendants,28–34 polypeptides with UCSTs in water have been rarely reported. Recently, we have demonstrated that helical polypeptides bearing 1-butylimidazolium groups and I− or BF4− counter-anions exhibited UCST-type transitions in water.35 By following that study, we designed a series of polypeptides bearing various pyridinium salts, aiming to expand our understanding of their structure–property relationship.
In this contribution, we report a new family of α-helical polypeptides bearing various pyridinium groups (i.e., pyridinium, 2-methylpyridinium, 3-methylpyridinium, and 4-methylpyridinium) and counter-anions (i.e., Cl− or BF4−) prepared by the combination of post-polymerization (i.e., nuleophilic substitution) and ion-exchange reaction. The molecular structures and conformations have been characterized by a combination of spectroscopic techniques (i.e., NMR, FTIR, and CD). Their UCST-type phase transition behaviors have been investigated by variable-temperature UV-vis spectroscopy.
CHN–), 8.47–8.48 (d, 1H, –CHCH
CCH3–), 8.06–8.10 (t, 1H, –CH
CHCH
), 4.65–4.64 (d, 2H, –NCH2CH2–), 4.30 (s, 1H, –COCHNH–), 3.95 (s, 2H, –OCH2CH2–), 2.49 (s, 3H, –PyCH3), 2.34 (s, 2H, –CH2CH2CH2N–), 1.24–1.94 (m, 10H, –CH2CH2CH2N–, –CH2CH2CH2CH2O–, –OCOCH2CH2–). 1H NMR of P1 (D2O, δ, ppm): 8.89–8.93 (d, 2H, –NCH
CH– and –N
CHCH–), 8.56–8.63 (q, 2H, –CH
CHCH– and –N
CHCH
CH–), 8.11–8.14 (t, 1H, –CCH
CH–), 4.75 (s, 2H, –NCH2CH2–), 4.35 (s, 1H, –COCHNH–), 4.23 (s, 2H, –OCH2CH2–), 1.87–2.44 (m, 6H, –NCH2CH2CH2–, –OCOCH2CH2–). 1H NMR of P3 (DMSO-d6, δ, ppm): 9.24 (s, 1H, –NCH
CH–), 9.12 (s, 1H, –CCH
CH–), 8.45 (s, 1H, –CH3CCH
CH–), 8.06 (s, 1H, –CH
CHCH
), 4.74 (s, 2H, –NCH2CH2–), 4.29 (s, 1H, –COCHNH–), 4.03 (s, 2H, –OCH2CH2–), 2.49 (s, 3H, –PyCH3), 2.27 (s, 2H, –CH2CH2CH2N–), 1.21–2.05 (t, 4H, –OCOCH2CH2–). 1H NMR of P4 (D2O, δ, ppm): 8.67–8.72 (t, 2H, –NCH
CH– and –N
CHCH–), 7.89–7.93 (t, 2H, –CH
CHCH– and –N
CHCH
CH–), 4.70 (s, 2H, –NCH2CH2–), 4.40 (s, 1H, –COCHNH–), 4.22 (s, 2H, –OCH2CH2–), 2.53 (s, 3H, –PyCH3), 2.41 (s, 2H, –CH2CH2CH2N–), 2.17–2.27 (m, 4H, –OCOCH2CH2–). 1H NMR of P5 (D2O, δ, ppm): 8.82 (s, 2H, –NCH
CH– and –N
CHCH–), 8.50 (s, 2H, –CH
CHCH– and –N
CHCH
CH–), 8.02 (s, 1H, –CCH
CH–), 4.55 (s, 2H, –NCH2CH2–), 3.99 (s, 3H, –COCHNH– and –OCH2CH2–), 1.19–1.95 (m, 12H, –NCH2CH2CH2–, –CH2CH2CH2CH2O–, –OCOCH2CH2–). 1H NMR of P8 (D2O, δ, ppm): 8.61 (s, 2H, –NCH
CH–), 7.82 (s, 2H, –CCH
CH–), 4.47 (s, 2H, –NCH2CH2–), 3.98 (s, 3H, –COCHNH– and –OCH2CH2–), 2.43 (s, 5H, –PyCH3 and –CH2CH2CH2N–), 1.29–2.17 (m, 10H, –CH2CH2CH2CH2O–, –OCOCH2CH2–).A representative post-polymerization for water-insoluble products (i.e., P2 and P6) is as follows. PCHLG (86.7 mg, 0.35 mmol of chlorine) was dissolved in DMF (2.0 mL) in a 25 mL flask under nitrogen, followed by adding acetonitrile (2.0 mL) solution of NaI (157 mg, 1.05 mmol) and 2-methylpyridine (68.6 μL, 0.7 mmol). The mixture was stirred at 80 °C for 48 h. Then, brine (13.0 mL) was added to the reaction solution, following by stirring at room temperature for 24 h to promote the ion exchange. The product was precipitated immediately and stuck on the glass wall. After that, cold DI water was used to wash the product to remove any solvent residue. Removing the solvent under vacuum afforded a glassy solid (74.0 mg, 63% yield). 1H NMR of P6 (DMSO-d6, δ, ppm): 8.98 (s, 1H, –NCH
CH–), 8.45 (s, 1H, –CCH
CH–), 8.03 (s, 1H, –CH3CCH
CH–), 7.96 (s, 1H, –CH
CHCH
), 4.51 (s, 2H, –NCH2CH2–), 4.31–4.36 (d, 1H, –COCHNH–), 3.95 (s, 2H, –OCH2CH2–), 2.49 (s, 3H, –PyCH3), 2.31 (s, 2H, –CH2CH2CH2N–), 1.25–1.82 (m, 10H, –CH2CH2CH2CH2O–, –OCOCH2CH2–). 1H NMR of P2 (DMSO-d6, δ, ppm): 9.05 (s, 1H, –NCH
CH–), 8.4 (s, 1H, –CCH
CH–), 8.16 (s, 1H, –CH3CCH
CH–), 8.05–7.96 (d, 1H, –CH
CHCH
), 4.66 (s, 2H, –CH2CH2CH2N–), 4.09 (s, 3H, –COCHNH– and –OCH2CH2–), 2.49 (s, 3H, –PyCH3), 2.34 (s, 2H, –CH2CH2CH2N–), 1.65–1.98 (t, 4H, –OCOCH2CH2–).
CHN–), 8.44–8.45 (d, 1H, –CHCH
CCH3–), 8.03–8.06 (t, 1H, –CH
CHCH
), 4.50–4.54 (d, 2H, –NCH2CH2–), 4.27 (s, 1H, –COCHNH–), 3.97 (s, 2H, –OCH2CH2–), 2.49 (s, 3H, –PyCH3), 2.30 (s, 2H, –CH2CH2CH2N–), 1.24–1.91 (m, 10H, –CH2CH2CH2N–, –CH2CH2CH2CH2O–, –OCOCH2CH2–). 1H NMR of P9 (DMSO-d6, δ, ppm): 9.04 (s, 2H, –NCH
CH– and –N
CHCH–), 8.58 (s, 2H, –CH
CHCH– and –N
CHCH
CH–), 8.13 (s, 1H, –CCH
CH–), 4.65 (s, 2H, –NCH2CH2–), 4.24 (s, 1H, –COCHNH–), 4.03 (s, 2H, –OCH2CH2–), 1.65–2.23 (m, 6H, –NCH2CH2CH2–, –OCOCH2CH2–). 1H NMR of P10 (DMSO-d6, δ, ppm): 8.94 (s, 1H, –NCH
CH–), 8.45 (s, 1H, –CCH
CH–), 8.02–8.16 (t, 1H, –CH3CCH
CH–), 7.94 (s, 1H, –CH
CHCH
), 4.60 (s, 2H, –NCH2CH2–), 4.21 (s, 1H, –COCHNH–), 4.08 (s, 2H, –OCH2CH2–), 2.49 (s, 3H, –PyCH3), 2.30 (s, 2H, –CH2CH2CH2N–), 1.73–1.98 (t, 4H, –OCOCH2CH2–). 1H NMR of P11 (DMSO-d6, δ, ppm): 8.95 (s, 1H, –NCH
CH–), 8.87 (s, 1H, –CCH
CH–), 8.41–8.43 (d, 1H, –CH3CCH
CH–), 8.02 (s, 1H, –CH
CHCH
), 4.60 (s, 2H, –NCH2CH2–), 4.25 (s, 1H, –COCHNH–), 4.05 (s, 2H, –OCH2CH2–), 2.49 (s, 3H, –PyCH3), 2.25 (s, 2H, –CH2CH2CH2N–), 1.66–1.83 (d, 4H, –OCOCH2CH2–). 1H NMR of P12 (DMSO-d6, δ, ppm): 8.84 (s, 2H, –NCH
CH– and –N
CHCH–), 7.92 (s, 2H, –CH
CHCH– and –N
CHCH
CH–), 4.54 (s, 2H, –NCH2CH2–), 4.20 (s, 1H, –COCHNH–), 3.99 (s, 2H, –OCH2CH2–), 2.54 (s, 3H, –PyCH3), 2.20 (s, 2H, –CH2CH2CH2N–), 1.64–1.79 (d, 4H, –OCOCH2CH2–). 1H NMR of P13 (DMSO-d6, δ, ppm): 9.03 (s, 2H, –NCH
CH– and –N
CHCH–), 8.56–8.58 (d, 2H, –CH
CHCH– and –N
CHCH
CH–), 8.13 (s, 1H, –CCH
CH–), 4.24–4.4.31 (d, 2H, –NCH2CH2–), 3.93 (s, 3H, –COCHNH– and –OCH2CH2–), 1.27–2.27 (m, 12H, –NCH2CH2CH2–, –CH2CH2CH2CH2O–, –OCOCH2CH2–). 1H NMR of P14 (DMSO-d6, δ, ppm): 8.93 (s, 1H, –NCH
CH–), 8.42–8.44 (d, 1H, –CCH
CH–), 8.16–7.94 (q, 2H, –CH3CCH
CH– and –CH
CHCH
), 4.49 (s, 2H, –NCH2CH2–), 4.23 (s, 1H, –COCHNH–), 3.95–4.04 (d, 2H, –OCH2CH2–), 2.49 (s, 3H, –PyCH3), 2.28 (s, 2H, –CH2CH2CH2N–), 1.28–1.81 (m, 10H, –CH2CH2CH2CH2O–, –OCOCH2CH2–). 1H NMR of P16 (DMSO-d6, δ, ppm): 8.86 (s, 2H, –NCH
CH–), 7.95 (s, 2H, –CCH
CH–), 4.47 (s, 2H, –NCH2CH2–), 4.22 (s, 1H, –COCHNH–), 3.92 (s, 2H, –OCH2CH2–), 2.57 (s, 3H, –PyCH3), 2.27 (s, 2H, –CH2CH2CH2N–), 1.25–1.84 (m, 10H, –CH2CH2CH2CH2O–, –OCOCH2CH2–).Poly(γ-3-propyl-L-glutamate)-N-pyridinium-chloride conjugate (P1), poly(γ-3-propyl-L-glutamate)-N-y-methylpyridinium-chloride conjugates (y = 2, P2; y = 3, P3; y = 4, P4), poly(γ-6-hexyl-L-glutamate)-N-pyridinium-chloride conjugate (P5), and poly(γ-6-hexyl-L-glutamate)-N-y-methylpyridinium-chloride conjugates (y = 2, P6; y = 3, P7; y = 4, P8) were synthesized by post-polymerizations of PCPLG or PCHLG with pyridine or y-methylpyridine (y = 2, 3, and 4) in 80 °C N,N-dimethyl-formamide (DMF) under nitrogen (Scheme 1). Sodium iodide (NaI) was used to promote the reaction. The products were purified by dialyzing against NaCl aqueous solution and DI H2O to remove the excess reactants and DMF. The molecular structures of P1–P8 (Table 1) were verified by 1H NMR (Fig. 1) and FTIR (Fig. 2). 1H NMR spectra of the polymers were consistent with their molecular structures. The grafting density was in the range of 90–94%, which was calculated based on the integration of 1H NMR resonances of Hd and Hi for P3 (Fig. 1a) or Hk for P7 (Fig. 1c). In the FTIR spectra, P1–P8 showed characteristic peaks at 3286, 2937, and 1720 cm−1, which corresponded to N–H stretching (vN–H), C–H stretching (vC–H), and C
O of ester bond stretching (vC
O), respectively (Fig. 2). The C–H deformation mode (δC–H) of pyridinium was in the range of 770–830 cm−1 depending on the types of pyridinium salts. Additionally, the amide I band at ∼1650 cm−1 suggested the α-helical conformation of P1–P8 in the solid-state.39
![]() | ||
| Scheme 1 The synthetic route of poly(γ-3-propyl-L-glutamate) or poly(γ-6-hexyl-L-glutamate) bearing various pyridinium salts. | ||
| Name | Mna | Mw/Mnb | DPc | x | Rd | X−e | fHf | Tptg (°C) |
|---|---|---|---|---|---|---|---|---|
| a Number-average molecular weight calculated from the degree of polymerization of the precursors (i.e., PCPLG and PCHLG) plus the respective molecular weight of various pyridinium groups added.b Molecular weight distribution of the precursors determined by GPC.c Degree of polymerization of the precursors calculated from the GPC results.d Substituent group of pyridinium.e Counter-anions.f Fractional helicity.g UCST-type transition temperature in DI H2O (20 mg mL−1). | ||||||||
| P1 | 7700 | 1.33 | 27 | 1 | H | Cl− | 24.7 | — |
| P2 | 8060 | 1.33 | 27 | 1 | 2-Me | Cl− | — | — |
| P3 | 8060 | 1.33 | 27 | 1 | 3-Me | Cl− | 26.6 | — |
| P4 | 8060 | 1.33 | 27 | 1 | 4-Me | Cl− | 28.1 | — |
| P5 | 8500 | 1.57 | 26 | 4 | H | Cl− | 34.3 | — |
| P6 | 8860 | 1.57 | 26 | 4 | 2-Me | Cl− | — | — |
| P7 | 8860 | 1.57 | 26 | 4 | 3-Me | Cl− | 37.2 | — |
| P8 | 8860 | 1.57 | 26 | 4 | 4-Me | Cl− | 40.6 | — |
| P9 | 9080 | 1.33 | 27 | 1 | H | BF4− | — | — |
| P10 | 9450 | 1.33 | 27 | 1 | 2-Me | BF4− | — | — |
| P11 | 9450 | 1.33 | 27 | 1 | 3-Me | BF4− | 28.7 | 25.9 |
| P12 | 9450 | 1.33 | 27 | 1 | 4-Me | BF4− | — | — |
| P13 | 9830 | 1.57 | 26 | 4 | H | BF4− | — | — |
| P14 | 10 200 | 1.57 | 26 | 4 | 2-Me | BF4− | — | — |
| P15 | 10 200 | 1.57 | 26 | 4 | 3-Me | BF4− | 41.4 | 28.2 |
| P16 | 10 200 | 1.57 | 26 | 4 | 4-Me | BF4− | — | — |
Polypeptides bearing pyridinium and BF4− counter-anions, namely, poly(γ-3-propyl-L-glutamate)-N-pyridinium-tetrafluoro-borate conjugate (P9), poly(γ-3-propyl-L-glutamate)-N-y-methylpyridinium-tetrafluoroborate conjugates (y = 2, P10; y = 3, P11; y = 4, P12), poly(γ-6-hexyl-L-glutamate)-N-pyridinium-tetra-fluoroborate conjugate (P13), and poly(γ-6-hexyl-L-glutamate)-N-y-methyl-pyridinium-tetrafluoroborate conjugates (y = 2, P14; y = 3, P15; y = 4, P16) were synthesized by ion-exchange reactions in NaBF4 aqueous solution at room temperature (Scheme 1). All products were water-insoluble at room temperature and were purified by repeatedly washing with NaBF4 aqueous solution and DI H2O. 1H NMR (Fig. 1) and FTIR analysis (Fig. 2) confirmed the molecular structures of P9–P16 (Table 1) with BF4− counter-anions. The exchange reactions were nearly quantitative, as confirmed by the 1H NMR spectra which showed upfield shifts in the signals assignable to the pyridinium ring protons relative to the precursors (P1–P8). For instances, the chemical shift of Hg of pyridinium ring protons shifted from 9.24 ppm for P3 to 8.95 ppm for P11 while the chemical shift of Hj shifted from 9.28 ppm for P7 to 8.95 ppm for P15 (Fig. 1). In the FTIR spectra (Fig. 2), the appearance of B–F vibration mode (vB–F) at 1037 cm−1 further confirmed the success of ion-exchange reaction. Additionally, P9–P16 adopted α-helical conformation in the solid-states, as verified by the amide I band at ∼1650 cm−1. GPC was used to characterize the molecular weights and molecular weight distributions of P1–P16. However, polypeptides with pyridinium groups were featureless due to the strong absorption between the charged side-chains and the stationary phase of GPC (Fig. S3†). Similar phenomenon has been observed in our previous publication.40
The solubility of the obtained polypeptides bearing different pyridinium groups and counter-anions were tested in various solvents ranging from highly polar dimethyl sulphoxide (DMSO) to less polar chloroform (Table 2). P1–P8 with Cl− counter-anions, namely, the Cl−-type polypeptides were soluble in polar solvents such as DMSO, water, and methanol except P2 and P6 with 2-methyl-pyridinium groups which showed poor solubility in methanol and water. Additionally, P1–P8 showed poor solubility in less polar solvent (e.g., chloroform and THF). In comparison, P9–P16 with BF4− counter-anions, namely, the BF4−-type polypeptides were soluble in DMSO except that P11 and P15 exhibited reversible UCST-type phase transitions in water (Fig. 3a). The solubility results suggested that the existence of methyl groups and medium hydrophobicity of the counter-anions (i.e., BF4−) are necessary conditions to show UCST-type solution phase transition behaviors in water. Similar results have been demonstrated in poly(vinyl ether)s with pendant imidazolium salts.41 Additionally, the specific methyl position in pyridinium groups (i.e., 3-substitution) also plays important role in the UCST-type transitions, which is likely related to the steric hindrance effect.42 More research effort is demanded to fully understand the structure–property relationship.
| Polymer | Chloroform | THF | Acetone | Ethanol | Methanol | H2O | DMSO |
|---|---|---|---|---|---|---|---|
| a S = soluble; I = insoluble; U = UCST-type phase transition; concentration = 10 mg mL−1. | |||||||
| P1 | I | I | I | I | S | S | S |
| P2 | I | I | I | I | I | I | S |
| P3 | I | I | I | I | S | S | S |
| P4 | I | I | I | I | S | S | S |
| P5 | I | I | I | S | S | S | S |
| P6 | I | I | I | I | I | I | S |
| P7 | I | I | I | S | S | S | S |
| P8 | I | I | I | S | S | S | S |
| P9 | I | I | I | I | I | I | S |
| P10 | I | I | I | I | I | I | S |
| P11 | I | I | I | I | I | U | S |
| P12 | I | I | I | I | I | I | S |
| P13 | I | I | I | I | I | I | S |
| P14 | I | I | I | I | I | I | S |
| P15 | I | I | I | I | I | U | S |
| P16 | I | I | I | I | I | I | S |
![]() | ||
| Fig. 3 (a) Optical image of P11 solutions at different temperatures. CD spectra of (b) P1, P3, P4, P11, and (c) P5, P7, P8, P15 in DI H2O (0.05 mg mL−1). | ||
The aqueous solution conformations of the polypeptides bearing different pyridinium salts were characterized by CD spectroscopy (Fig. 3b and c). All polypeptide samples showed characteristic CD bands at 208 and 222 nm, indicating an α-helical conformation in solution.43 The fractional helicity (fH) of the resulting polypeptides was calculated using eqn (1)44 to allow for a quantitative comparison of the relative helical content (Table 1).
fH = (−[θ]222 + 3000)/39 000
| (1) |
Polypeptide samples with hexyl spacer groups (i.e., P5, P7, P8, and P15) showed higher helicities (fH = 34.3–41.4%) than the samples with propyl spacer groups (i.e., P1, P3, P4, and P11, fH = 24.7–28.7%), suggesting that increasing the hydrophobicity of the spacer groups improved their helical stability. Additionally, the fH values for the samples with Cl− counter-anions (e.g., P3 and P7) was lower than the samples with BF4− counter-anions (e.g., P11 and P15), suggesting that counter-anions with smaller ionic radius and higher charge density may further increase the charge repulsions between adjacent pyridinium groups and subsequently destabilize the α-helical conformation.
The thermoresponsive behaviors of P11 and P15 in aqueous solutions were studied by variable-temperature UV-vis spectroscopy (Fig. 4 and 5). P11 and P15 were soluble in DI H2O at high temperatures, yet the solutions become turbid when cooling the solutions to respective UCST-type transition temperatures (Tpts), which lead to a sharp transition in the transmittance as monitored by UV-vis spectroscopy. The Tpts were determined at 50% of transmittance in the cooling cycle. At 20 mg mL−1, the aqueous solution of P15 with hexyl spacer groups showed a Tpt at 28.2 °C (Table 1) which was 2 °C higher than that of P11 with propyl spacer groups, suggesting that Tpt increased as increasing the hydrophobicity of the spacer groups. The effect of polymer concentrations (Fig. 4) and ionic strength (Fig. 5) on the Tpts was also investigated by UV-vis spectroscopy to further understand the mechanism of their solution phase transition behaviors. The Tpts were significantly affected by polymer concentrations and salts (i.e., NaX, X = Cl and BF4), suggesting that the mechanism of the thermoresponsive phase transition mainly ascribed to the electrostatic interactions.35,41,45 For examples, the Tpts increased from 6.4 °C to 25.9 °C for P11 and from 12.6 °C to 28.2 °C for P15 as the polymer concentrations increased from 10 mg mL−1 to 20 mg mL−1. The increment of Tpts for P15 was 4 °C lower than that for P11, indicating that increasing the hydrophobicity of the spacer groups improved their resistance to concentration change. In addition, the Tpts decreased as the NaCl concentration increased and increased as increasing the NaBF4 concentration, which was likely resulted from the anion exchange reactions and the difference of hydrophobicity between different counter-anions. We also noticed that P15 with more hydrophobic spacer groups (i.e., hexyl groups) showed less dependence on the variation of ionic strength than P11. For example, the concentration of NaBF4 for P15 (35.7 mM) was ∼2.7 times higher than that of P11 (13.3 mM) as increasing the Tpts to ∼50 °C.
![]() | ||
| Fig. 4 Variable-temperature UV-vis spectra of (a) P11 and (b) P15 aqueous solutions with different concentrations. | ||
![]() | ||
| Fig. 5 Variable-temperature UV-vis spectra of (a) P11 and (b) P15 aqueous solutions (10 mg mL−1) with different salt (i.e., NaCl or NaBF4) concentrations. | ||
Footnote |
| † Electronic supplementary information (ESI) available. See DOI: 10.1039/c5ra04541j |
| This journal is © The Royal Society of Chemistry 2015 |